AG Mednet, Inc. notes that Eli Lilly established a strategic collaboration with Amplitude Therapeutics to harness advanced generative AI models for drug discovery.
Public source
Publisher name
Public post
Big Pharma Meets Generative AI: Eli Lilly and Company Partners with Amplitude Therapeutics Eli Lilly has established a strategic collaboration with Amplitude Therapeutic…
Company
AG Mednet, Inc.
Welcome to the clinical trials revolution
- Industry
- Biotechnology Research
- Location
- Boston, US
- Company size
- 51–200 employees
About AG Mednet, Inc.
Judi by AG Mednet empowers the doers, clinical trial leaders, and medical innovators, with streamlined process management software, allowing them to focus on what they do best, providing breakthrough treatments and products. We remove unnecessary cost and effort, introducing greater control, enabling transparency, and allowing seamless collaboration, which speeds the time to market.
See moreLatest activity
Latest activity from AG Mednet, Inc.
3 signals
Legal & Regulatory
AG Mednet, Inc. secured FDA Fast Track designation for ERAS-0015, an investigational pan-RAS molecular glue targeted at patients with metastatic pancreatic adenocarcinoma.
Legal & Regulatory
AG Mednet, Inc. was informed that the U.S. Food and Drug Administration (FDA) finalized its guidance regarding formal sponsor meetings under the Prescription Drug User Fee Act (PDUFA) VII, replacing the previous draft issued in late 2023.
Discover more
Similar signals
Similar public activity from other companies.
Partnerships
Biotech Networks
Biotech Networks announced a collaboration with Takeda to deploy the Weave platform across 14 active programs in multiple global markets.
Partnerships
Aitia
Aitia announced a collaboration with ONO PHARMACEUTICAL CO., LTD. to discover novel neurological disease targets and develop effective new therapeutics using its causal AI-powered Gemini Digital Twin Platform.
Partnerships
Differentia Bio
Differentia Bio and HiRO - Harvest Integrated Research Organization announced a strategic partnership to bring simulation-first clinical trial design to biotech sponsors worldwide.
Partnerships
myNEO Therapeutics
myNEO Therapeutics partnered with Odimma Therapeutics to combine their AI-driven neoantigen discovery pipeline with tailor-made synthetic DNA technology for personalized treatment of cancer patients.
Partnerships
chAIron